CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to CORT

Relacorilant 150 mg once daily (QD)

Phase 3
Corcept Therapeutics Incorporated (CORT)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
CORTPhase 2

Relacorilant 150 mg once daily (QD) Phase 2 Est. Readout

Relacorilant 150 mg once daily (QD)
Aug 2026~STALE
CT.gov
00%
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.